What Do Tesla Delivery Numbers Mean for Tesla Stock?
Tesla (NASDAQ:TSLA) released Q1 delivery numbers, showing a substantial slowdown…
Sell
34
KVUE Quote, Financials, Valuation and Earnings
Last price:
$22.08
Seasonality move
:
-9.02%
Day range:
$21.41 - $22.11
52-week range:
$17.67 - $24.46
Dividend yield:
3.73%
P/E ratio:
41.26x
P/S ratio:
2.72x
P/B ratio:
4.32x
Volume:
17M
Avg. volume:
16.7M
1-year change:
8.05%
Market cap:
$41.8B
Revenue:
$15.5B
EPS (TTM):
$0.53
Analysts' Opinion
-
Consensus RatingKenvue has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 14 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $24.21, Kenvue has an estimated upside of 10.69% from its current price of $21.87.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $21.00 representing 3.98% downside risk from its current price of $21.87.
Fair Value
-
According to the consensus of 17 analysts, Kenvue has 10.69% upside to fair value with a price target of $24.21 per share.
KVUE vs. S&P 500
-
Over the past 5 trading days, Kenvue has underperformed the S&P 500 by -10.82% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Kenvue does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Kenvue revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Kenvue reported revenues of $3.7B.
Earnings Growth
-
Kenvue has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Kenvue reported earnings per share of $0.15.
Enterprise value:
49.2B
EV / Invested capital:
--
Price / LTM sales:
2.72x
EV / EBIT:
26.66x
EV / Revenue:
3.18x
PEG ratio (5yr expected):
--
EV / Free cash flow:
36.87x
Price / Operating cash flow:
31.51x
Enterprise value / EBITDA:
19.94x
Gross Profit (TTM):
$9B
Return On Assets:
3.84%
Net Income Margin (TTM):
6.67%
Return On Equity:
9.84%
Return On Invested Capital:
5.43%
Operating Margin:
15.21%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $15B | $15.4B | $15.5B | $3.7B | $3.7B | |
| Gross Profit | $8.3B | $8.6B | $9B | $2B | $2.1B | |
| Operating Income | $2.7B | $2.5B | $2.6B | $466M | $557M | |
| EBITDA | $3.3B | $3.2B | $2.5B | $735M | $644M | |
| Diluted EPS | $1.10 | $0.88 | $0.53 | $0.17 | $0.15 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $4.9B | $5.9B | $6.1B | $5.5B | |
| Total Assets | -- | $27.9B | $27.3B | $27.9B | $25.6B | |
| Current Liabilities | -- | $4B | $3.9B | $5.5B | $5.7B | |
| Total Liabilities | -- | $7.5B | $7.3B | $16.6B | $15.9B | |
| Total Equity | -- | $20.4B | $20B | $11.2B | $9.7B | |
| Total Debt | -- | -- | -- | $8.3B | $8.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.5B | $3.2B | $1.8B | $950M | $793M | |
| Cash From Investing | -$390M | -$488M | -$425M | -$265M | -$132M | |
| Cash From Financing | -$1.6B | -$2.5B | -$1.6B | -$383M | -$587M | |
| Free Cash Flow | $2.2B | $2.7B | $1.3B | $727M | $661M | |
KVUE
Sector
Market Cap
$41.8B
$259.5M
Price % of 52-Week High
89.41%
70.58%
Dividend Yield
3.73%
0%
Shareholder Yield
4.22%
3.11%
1-Year Price Total Return
8.05%
-14.09%
Beta (5-Year)
--
0.416
Dividend yield:
3.73%
Annualized payout:
$0.81
Payout ratio:
150.68%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$22.58
200-day SMA
Buy
Level
$21.75
Bollinger Bands (100)
Sell
Level
21.22 - 23.56
Chaikin Money Flow
Sell
Level
-177.7M
20-day SMA
Sell
Level
$23.07
Relative Strength Index (RSI14)
Sell
Level
37.53
ADX Line
Sell
Level
26.29
Williams %R
Neutral
Level
-72.1713
50-day SMA
Sell
Level
$22.51
MACD (12, 26)
Sell
Level
-0.21
25-day Aroon Oscillator
Sell
Level
-88
On Balance Volume
Sell
Level
-82.7M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.3652)
Sell
CA Score
(Annual)
Level (-0.4292)
Buy
Beneish M-Score
(Annual)
Level (-2.6177)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (0.1696)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (5)
Sell
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Kenvue is the world’s largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson’s consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women’s health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson’s, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue’s brands are the global leader in their respective segment thanks to their strong brand power.
Stock Forecast FAQ
In the current month, KVUE has received 3 Buy ratings 14 Hold ratings, and 0 Sell ratings. The KVUE average analyst price target in the past 3 months is $24.21.
-
Where Will Kenvue Stock Be In 1 Year?
According to analysts, the consensus estimate is that Kenvue share price will rise to $24.21 per share over the next 12 months.
-
What Do Analysts Say About Kenvue?
Analysts are divided on their view about Kenvue share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Kenvue is a Sell and believe this share price will drop from its current level to $21.00.
-
What Is Kenvue's Price Target?
The price target for Kenvue over the next 1-year time period is forecast to be $24.21 according to 17 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 14 analysts rate the stock a Hold.
-
Is KVUE A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Kenvue is a Hold. 14 of 17 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of KVUE?
You can purchase shares of Kenvue via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Kenvue shares.
-
What Is The Kenvue Share Price Today?
Kenvue was last trading at $22.08 per share. This represents the most recent stock quote for Kenvue. Yesterday, Kenvue closed at $21.87 per share.
-
How To Buy Kenvue Stock Online?
In order to purchase Kenvue stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Chewy a Growth Stock to Buy?
It might be a surprise to learn that during the…
Is Realty Income the Best Dividend Stock to Buy Long-Term?
Realty Income (NYSE:O) is a longstanding real estate investment trust…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 31x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
42
Is NVDA Stock a Buy?
Market Cap: $2.6T
P/E Ratio: 37x
Alerts
Sell
11
CRL alert for Apr 11
Charles River Laboratories International [CRL] is down 0.2% over the past day.
Buy
77
DPST alert for Apr 11
Direxion Daily Regional Banks Bull 3X Shares [DPST] is down 0.79% over the past day.
Sell
35
KMX alert for Apr 11
CarMax [KMX] is up 2.87% over the past day.
